For example, pridopidine, the selective Sig-1R agonist, displayed potential efficacy in amyotrophic lateral sclerosis, Alzheimer’s, and Huntington’s disease preclinical or clinical studies [63,64]. Here, SIGMAR1 is linked to juvenile Huntington disease.